Appointment supports AstraZeneca’s $50 billion US investment and ambition to reach $80 billion in Total Revenue by 2030
The partnership builds on a prior collaboration between Nimbus and Lilly targeting AMPK in cardiometabolic diseases
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
The primary goal of the collaboration is joint research into trending and next-generation molecules
The move strengthens GBL’s clinical-stage presence in the United States
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
The partnership aims to develop novel, selective small molecules targeting TDP-43 pathology
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
Subscribe To Our Newsletter & Stay Updated
